265 related articles for article (PubMed ID: 30616019)
1. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.
Brook E; Mamo J; Wong R; Al-Salami H; Falasca M; Lam V; Takechi R
Pharmacol Res; 2019 Mar; 141():291-297. PubMed ID: 30616019
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor protects against blood-brain barrier dysfunction in a mouse model of type 2 diabetes via the AMPK/HO-1 pathway.
Wu J; Zhao Y; Fan Z; Chen Q; Chen J; Sun Y; Jiang X; Xiao Q
Biochem Biophys Res Commun; 2020 Apr; 524(2):354-359. PubMed ID: 32001002
[TBL] [Abstract][Full Text] [Related]
3. Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective.
Lam V; Hackett M; Takechi R
Nutrients; 2016 Dec; 8(12):. PubMed ID: 27999412
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline.
Liu L; Wang N; Kalionis B; Xia S; He Q
J Neuroimmunol; 2022 Jan; 362():577763. PubMed ID: 34844084
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier impairment in dementia: current and future in vivo assessments.
van de Haar HJ; Burgmans S; Hofman PA; Verhey FR; Jansen JF; Backes WH
Neurosci Biobehav Rev; 2015 Feb; 49():71-81. PubMed ID: 25524876
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier disruption in atrial fibrillation: a potential contributor to the increased risk of dementia and worsening of stroke outcomes?
Aryal R; Patabendige A
Open Biol; 2021 Apr; 11(4):200396. PubMed ID: 33878948
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-γ activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice.
Min LJ; Mogi M; Shudou M; Jing F; Tsukuda K; Ohshima K; Iwanami J; Horiuchi M
Hypertension; 2012 May; 59(5):1079-88. PubMed ID: 22454480
[TBL] [Abstract][Full Text] [Related]
8. Improvement of autophagy dysfunction as a potential mechanism for environmental enrichment to protect blood-brain barrier in rats with vascular cognitive impairment.
Xu L; Qu C; Qu C; Shen J; Song H; Li Y; Li T; Zheng J; Zhang J
Neurosci Lett; 2020 Nov; 739():135437. PubMed ID: 33132180
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoids, Blood-Brain Barrier, and Brain Disposition.
Calapai F; Cardia L; Sorbara EE; Navarra M; Gangemi S; Calapai G; Mannucci C
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32183416
[TBL] [Abstract][Full Text] [Related]
10. Anti-RAGE antibody attenuates isoflurane-induced cognitive dysfunction in aged rats.
Shi C; Yi D; Li Z; Zhou Y; Cao Y; Sun Y; Chui D; Guo X
Behav Brain Res; 2017 Mar; 322(Pt A):167-176. PubMed ID: 28115220
[TBL] [Abstract][Full Text] [Related]
11. Dementia-like pathology in type-2 diabetes: A novel microRNA mechanism.
Kalani A; Chaturvedi P; Maldonado C; Bauer P; Joshua IG; Tyagi SC; Tyagi N
Mol Cell Neurosci; 2017 Apr; 80():58-65. PubMed ID: 28219659
[TBL] [Abstract][Full Text] [Related]
12. Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus.
Groeneveld O; Reijmer Y; Heinen R; Kuijf H; Koekkoek P; Janssen J; Rutten G; Kappelle L; Biessels G;
Nutr Metab Cardiovasc Dis; 2018 Dec; 28(12):1253-1260. PubMed ID: 30355471
[TBL] [Abstract][Full Text] [Related]
13. Role of microRNAs on Blood Brain Barrier Dysfunction in Vascular Cognitive Impairment.
Toyama K; Spin JM; Tsao PS
Curr Drug Deliv; 2017 Sep; 14(6):744-757. PubMed ID: 27572324
[TBL] [Abstract][Full Text] [Related]
14. Disturbed sleep and diabetes: A potential nexus of dementia risk.
Holingue C; Wennberg A; Berger S; Polotsky VY; Spira AP
Metabolism; 2018 Jul; 84():85-93. PubMed ID: 29409842
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Antidiabetic Medications in the Treatment of Cognitive Dysfunction and Dementia.
Umegaki H
Drugs Aging; 2016 Jun; 33(6):399-409. PubMed ID: 27138956
[TBL] [Abstract][Full Text] [Related]
16. Effects of Exercise on Type 2 Diabetes Mellitus-Related Cognitive Impairment and Dementia.
Callisaya M; Nosaka K
J Alzheimers Dis; 2017; 59(2):503-513. PubMed ID: 28598841
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of the retina for identifying people with type 2 diabetes with prodromal stages of dementia.
Ciudin A; Hernández C; Simó-Servat O; Simó R
Neurosci Biobehav Rev; 2024 Apr; 159():105592. PubMed ID: 38365136
[TBL] [Abstract][Full Text] [Related]
18. The diabetic brain and cognition.
Riederer P; Korczyn AD; Ali SS; Bajenaru O; Choi MS; Chopp M; Dermanovic-Dobrota V; Grünblatt E; Jellinger KA; Kamal MA; Kamal W; Leszek J; Sheldrick-Michel TM; Mushtaq G; Meglic B; Natovich R; Pirtosek Z; Rakusa M; Salkovic-Petrisic M; Schmidt R; Schmitt A; Sridhar GR; Vécsei L; Wojszel ZB; Yaman H; Zhang ZG; Cukierman-Yaffe T
J Neural Transm (Vienna); 2017 Nov; 124(11):1431-1454. PubMed ID: 28766040
[TBL] [Abstract][Full Text] [Related]
19. Cerebral microvascular endothelial glycocalyx damage, its implications on the blood-brain barrier and a possible contributor to cognitive impairment.
Stoddart P; Satchell SC; Ramnath R
Brain Res; 2022 Apr; 1780():147804. PubMed ID: 35101385
[TBL] [Abstract][Full Text] [Related]
20. Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective.
Biessels GJ; Nobili F; Teunissen CE; Simó R; Scheltens P
Lancet Neurol; 2020 Aug; 19(8):699-710. PubMed ID: 32445622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
